Virios therapeutics to present at the h.c. wainwright 23rd annual global investment conference

Atlanta--(business wire)---- $viri #biotech--virios therapeutics, inc. (nasdaq: viri), a clinical-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, announced today that greg duncan, chairman and chief executive officer, will present a company overview at the h.c. wainwright 23rd annual global investment conference which is taking place virtually september 13 – 15, 2021. the presentation will focus on the role of activated viruses trigge
VIRI Ratings Summary
VIRI Quant Ranking